What if the cashew nut shell — an abundant by-product in several African countries — became a key ingredient in the manufacture of messenger RNA vaccines This is the promising avenue being explored by a team of South African researchers.
A scientific discovery with strong potential
The oil extracted from the cashew shell can be processed into ionizable lipids — these «lipid bubbles» that transport RNA to the cells of our body. Until now, these lipids came mainly from petrochemical derivatives, costly and dependent on foreign patents. This discovery opens a new path towards autonomy.
A double opportunity for Africa
- 🌱 Promoting a local resource Under-exploited — the cashew nut, cultivated throughout West Africa
- 🛡️ Gaining vaccine sovereignty and reduce dependence on imports and foreign patents
A new horizon for clinical research
For clinical research professionals, this advance opens up a new perspective: imagining... trials of locally produced, formulated and distributed vaccines, with a more resilient value chain rooted in the African continent.
At AFCRA SMO, we closely monitor these developments and encourage collaboration between research, industry, regulatory bodies, and the agricultural and pharmaceutical sectors. Together, let's position Africa not just as a consumer of vaccines, but as a player capable of innovating and producing for its people.
— The AFCRA SMO Team
🔗 Source: Trust My Science | 🌐 www.afcra-smo.org
Tags: #Africa | #Vaccins | #RNAm | #RechercheClinique | #SoverainetéSanitaire | #NixDeCashou | #PharmaAfrica